NeoGenomics, Inc.
NASDAQ:NEO
Overview | Financials
Company Name | NeoGenomics, Inc. |
Symbol | NEO |
Currency | USD |
Price | 14.14 |
Market Cap | 1,812,154,106 |
Dividend Yield | 0% |
52-week-range | 12.77 - 21.22 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Christopher Michael Smith BSc |
Website | https://www.neogenomics.com |
An error occurred while fetching data.
About NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD